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Abstract
Background: Invariant natural killer T (iNKT) cells differ from other T cells by their hyperactive effector T-cell status,
in addition to the expression of NK lineage receptors and semi-invariant T-cell receptors. It is generally agreed that
the immune phenotype of iNKT cells is maintained by repeated activation in peripheral tissues although no explicit
evidence for such iNKT cell activity in vivo has so far been reported.
Results: We used an interferon (IFN)-g-inducible cytoplasmic protein, Irga6, as a histological marker for local IFN-g
production. Irga6 was intensely expressed in small foci of liver parenchymal cells and kidney tubular epithelium.
Focal Irga6 expression was unaffected by germ-free status or loss of TLR signalling and was totally dependent on
IFN-g secreted by T cells in the centres of expression foci. These were shown to be iNKT cells by diagnostic T cell
receptor usage and their activity was lost in both CD1 d and Ja-deficient mice.
Conclusions: This is the first report that supplies direct evidence for explicit activation events of NKT cells in vivo
and raises issues about the triggering mechanism and consequences for immune functions in liver and kidney.
Background
Invariant natural killer-like T (iNKT) cells are placed
ambiguously between adaptive and innate immune sys-
tems (reviewed in [1,2]). Derived from the thymus,
expressing rearranged T-cell receptor (TCR) alpha and
beta chains, they seem to belong to the adaptive
immune system, while their receptor homogeneity, their
continuous state of activation, their rapid secretion of
large amounts of interferon (IFN)-g and interleukin
(IL)-4, their presumed recognition of invariant glycolipid
self-ligands associated with the non-classical major his-
tocompatibility (MHC) class I molecule, CD1 d, recall
various aspects of innate immune recognition. Many
features of iNKT cell behaviour are puzzling: their thy-
mic ontogeny and relation to the classical pathways of
T-cell mediated differentiation; the relative importance
of endogenous and exogenous ligands in activation; and
the polarity of their cytokine profile towards IFN-g or
IL-4 in relation to the activating ligand. However, in this
report we address the basis for another characteristic of
these enigmatic cells, namely their constitutive state of
readiness to respond with massive cytokine production
(reviewed in [3]). Using a sensitive endogenous reporter
for IFN-g production, we show that iNKT cells are con-
stitutively and endogenously activated to IFN-g produc-
tion in the liver and kidney of normal mice. The
activation is apparently restricted to these tissues, focal,
spontaneous and independent of signals derived from
bacteria or viruses. It is, however, dependent on the
expression of CD1 d and on the presence of the classical
iNKT cell receptor. The results suggest that the consti-
tutive state of iNKT readiness may be maintained by
intermittent local stimulation with endogenous ligands.
Results and discussion
We recently demonstrated the constitutive expression of
the IFN-g-inducible, immunity-related GTPase, Irga6, in
hepatic parenchymal cells of normal mice [4]. This was
attributed to the presence of a dedicated, liver-specific
promoter associated with this innate immune resistance
gene. During these studies we noticed that the expres-
sion of Irga6 in hepatic parenchymal cells was not uni-
form. Small focal patches, each consisting of a few to a
few dozen contiguous cells, expressed very much more
Irga6 than the general expression level (Figure 1A).
These foci of high Irga6 expression resembled those that
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Figure 1 Focal expression of Irga6 in healthy mouse liver and kidney. (A) Irga6 is expressed focally in the liver and kidney. Paraffin sections
of C57BL/6 healthy adult mice liver and kidney were probed for Irga6 protein (green). In liver the parenchyma, between the high expression
foci, is stained uniformly with Irga6 as a result of transcription from the liver-specific Irga6 promoter [4]. Two types of Irga6 focal expression in
liver are depicted: a stained patch without an evident core (P) and a patch with a mononuclear cell core (cored patch, CP). Here and in (B) the
microscope magnification is 200×; frames show enlargements. (B) T cells and macrophages/dendritic cells are present in the mononuclear cores
of the liver and kidney patches. Wax sections of the livers and kidneys from adult C57BL/6 mice were stained for Irga6 (brown/red) and CD3 or
F4/80 (blue). For Irga6 and CD3 double staining in liver, consecutive serial sections were analysed (numbered 1, 2, 3, 4). Arrows point to CD3 and
F4/80 positive cells; frames show enlargements. (C) Irga6 focal expression is developmentally regulated. Wax sections through whole livers and
kidneys from C57BL/6 newborn mice and mice, aged as indicated, were stained for Irga6. High expression foci were counted within multiple
microscopic fields (see Methods section). Each value in the histogram represents the mean of 30 such counts for organs from two mice of each
age (error bars indicate standard deviations).
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we reported in the kidney parenchyma associated with
tubular epithelium [4]. About 10% of high expression
foci in the liver were characterized by a central accumu-
lation of small mononuclear cells. We could establish
immunohistologically that T cells, defined by CD3, and
macrophage/DC lineage cells, defined by F4/80, were
present in these mononuclear cell cores (Figure 1B).
The same cell types could be found adjacent to the
patches of high Irga6 expression in the kidney cortical
tubular epithelium, following closely the pattern of F4/
80+ DC described in mouse kidney [5]. In subsequent
analysis of the liver we distinguished between the min-
ority of Irga6 expression patches with and the majority
without, visible mononuclear cell cores (see Materials
and Methods), as they clearly have different origins (see
below). There are mononuclear cells associated with all
kidney patches and the patches seem to have only one
origin (see below). High Irga6 expression patches are
not present in newborn mice but develop rapidly in
both the kidney and liver between 1 week and 3 weeks
after birth (Figure 1C).
As Irga6 expression is induced by IFN-g [6,7], we
asked whether high expression patches were due to the
local expression of IFN-g. First, we examined the liver
and kidneys of mice with genomic disruptions of com-
ponents of the IFN response mechanism on the C57BL/
6 background (Figure 2AAdditional file 1: Table S1.
Both IFN-g [8] and IFN-gamma receptor (IFNGR) [9]
deficiencies eliminated all high Irga6 expression patches
from the kidney and all Irga6 patches with mononuclear
cores from the liver. The liver patches without cores
were not significantly affected. IFNAR deficiency [10]
had no marked effect on either organ. As expected, all
kidney patches and liver patches with mononuclear
cores were eliminated by STAT-1 deficiency. Surpris-
ingly, the high expression patches without mononuclear
cell cores were also absent in the STAT-1-deficient
livers, even though the loss of type I and type II IFN
receptors had no effect on them. We conclude that
coreless liver patches are caused by the local action of
another cytokine probably not of lymphoid origin, per-
haps IFN-l (IL-29) or IL-27 which both transduce sig-
nals via STAT1 in hepatocytes, but initiate signalling
through distinct receptors [11,12]. Rag1 deficiency [13]
behaved like IFN-g or IFNGR deficiency, eliminating all
Irga6 high expression foci with mononuclear cores from
the liver, showing that lymphocytes with rearranged
receptor chains were required for the focal expression
patches with mononuclear cell cores but not for
the coreless patches. It was not possible to assess
high expression patches in kidney because of near uni-
versal high expression in these organs (Additional file 2:
Figure S1). No liver phenotype was detected in B-cell-
deficient JHT mice [14], excluding B cells from further
consideration. Again, excessive high expression was
found in the kidneys (Additional file 2: Figure S1).
Secondly, if IFN-g is responsible for the focal induc-
tion of Irga6, there should be activation in the high
expression patches of the IFN-g-dependent promoter of
the Irga6 gene, with the use of exon 1A, in contrast
to the general hepatic parenchyma in which the liver-
specific promoter is constitutively expressed with usage
of exon 1B [4]. We therefore isolated high expression
patches and areas of general expression level by laser
microdissection and used quantitative real-time poly-
merase chain reaction (qRT-PCR) in order to identify
the use of the IFN-g-dependent 5’-untranslated 1A exon
and the constitutively expressed 5’-untranslated 1B exon
in the two tissue sites (Figure 2C). Expression of the
IFN-g-dependent exon 1A was 27.5× higher by qRT-
PCR in the high expression patches than in the general
liver, while 1B exon expression was not altered (1.5×).
However, when the Irga6-1A PCR products from the
general liver were cloned and sequenced, only 5.9% of
were specific (a consequence of the very low absolute
expression of the IFN-g-inducible transcript in non-focal
hepatic parenchyma), while 100% of those cloned from
the high expression patches were specific. Thus, the true
excess of Irga6-1A in the high expression patches rela-
tive to the general parenchyma was 100 × 27.9/5.9 or
about 470×, confirming the intense local induction by
IFN-g.
Thirdly, if IFN-g is being secreted locally, affected cells
should express not only Irga6 but also other members
of the IFN-g-inducible IRG protein family that are not
constitutively expressed in hepatic parenchymal cells [4].
We therefore stained adjacent histological sections of
liver and kidney for Irga6 and for Irgm3. Indeed, focal
expression of Irgm3 coincided accurately with the high
Irga6 expression patches (Additional file 3: Figure S2).
Direct evidence for the expression of IFN-g in the
patches with mononuclear cell cores, but not in the
coreless patches, was obtained by RT-PCR for IFN-g
transcripts in microdissected patch material. A strong
signal for IFN-g was recovered from only the patches
with mononuclear cell cores (Figure 2D). These experi-
ments established beyond doubt that the liver and
kidney contain reactive foci of local, T-cell-dependent
IFN-g production identified by the local high expression
of Irga6.
The character of the small IFN-g-secreting reactive
foci in the liver and kidney suggested that they could be
due to local immune activity stimulated by microbial
material. We therefore analysed the liver and kidney for
reactive foci from mice deficient in components of the
Toll-le receptor (TLR) system (Figure 2B). No effects
were seen in mice deficient in TLR2, 4 or 9 or MyD88,
arguing against bacterial components as the initiators of
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Figure 2 Focal expression of Irga6 is dependent on interferon (IFN)-pathway. (A) Focal expression of Irga6 is eliminated in mice deficient
in the IFNg-response pathway. High Irga6 expression foci were counted in livers and kidneys from two mice deficient in IFN-pathway
components and from two appropriate control wild-type (WT) mice as described (see Methods section). Focus numbers from knockout (KO)
organs are presented as a percentage of the focus numbers in control WT mice (ko/wt). For raw data see Additional file 1: Table S1. Kidneys of
RAG-/- and JHT strain could not be analysed (ND), because of generally elevated Irga6 expression (Additional file 2: Figure S1). (B) Irga6 focal
expression is not triggered by immune responses to microbial components. Irga6 focal expression was assayed in organs from mice deficient in
TLR2/4 and TLR9, MyD88 and germ-free (GF) mice. GF mice came from three different sources [GF(P) Portugal, GF(CH) Switzerland, GF(S)
Sweden]. (C) IFNg-inducible transcripts of Irga6 (1A) dominate focal expression in liver. IFNg-inducible (Irga6-1A) and liver-specific (Irga6-1B)
transcripts were quantitated by quantitative real-time polymerase chain reaction (RT-PCR) from focal (F) and non-focal (NF) material isolated from
stained tissue sections by laser microdissection (top left: left panel, liver section before microdissection of cored patch; middle panel, after
microdissection; right panel, microdissected patch). Irga6-1A and Irga6-1B transcripts were amplified using selective primers for the 1A and 1B 5’-
exons and a common 3’ primer in the coding exon (top right). The ratio of expression of 1A to 1B is given for F and for NF (bottom left) as the
mean of two independent experiments (error bars indicate standard deviations). Twenty clones amplified for Irga6-1A from both F and NF were
sequenced. The dominance of Irga6-1A in F is very high since only 5.9% of clones amplified for 1A from NF liver were specific for Irga6-1A,
compared with 100% from F (see Methods section). (D) IFN-g is expressed in liver cored patches. Total liver tissues (liver), Irga6 liver patches (P)
and CP were collected as described (C). RT-PCR was carried out using IFN-g specific primers and the products run in an agarose gel. GAPDH was
used as control.
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the foci. In order to test this conclusion further, we
examined the liver and kidney from germ-free mice
from three independent sources. No significant reduc-
tion in numbers of reactive foci in liver or spleen was
detected (Figure 2B). Bacterial infection is, thus, unlikely
to be a stimulus for the reactive foci
Two further explanations were considered for the
focal IFN-g production. One was the local re-expression
of an endogenous mouse mammary tumour virus
(MMTV) open reading frame acting as a superantigen
(reviewed in [15]). The other was local activation of
iNKT cells. These two possibilities could be distin-
guished by a knowledge of the V gene usage of T cells
in the mononuclear cores. In the case of a superantigen,
specific Vb families should be favoured, but no specific
Va usage, while in iNKT cells, a specific and diagnostic
pattern of Vb8/Va14Ja18 could be anticipated [16]. We
used laser microdissection to isolate and pool the mono-
nuclear cell cores from many high Irga6 expression
patches and employed semi-nested PCR on reverse-tran-
scribed cDNA to amplify, and subsequently clone, Va
and Vb from expressed TCRs. The result for Vb usage
was striking, namely, the exclusive usage of the three
Vb8 genes, with an excess of Vb8.2 (Figure 3A and 3C)
in contrast to the diversity of Vb genes recovered by the
same technique from lymph node lymphocytes. We
were able to confirm the high use of Vb8 in mononuc-
lear core T cells immunohistologically with a specific
anti-Vb8 monoclonal antibody (Figure 3B). Vb8 is
uncommon, but not unknown, as a MMTV superanti-
gen target [15] but is part of the diagnostic receptor
combination of iNKT cells [16]. We therefore amplified
Figure 3 Semi-invariant T-cell receptor (TCR) Vb8:Va14-Ja18 is preferentially used by T cells in Irga6 liver cored patches. (A) TCR Vb8 is
used preferentially in Irga6 liver cored patches. TCR Vb sequences were amplified by nested-real-time polymerase chain reaction (RT PCR) and
sequenced from microdissected cored patches as described (Methods). Lymph node cells (LN) served as control. In total 68 and 132 Vb clones
for liver cored patch (CP) and lymph node (LN) T cells were identified, respectively. The histogram shows the distribution of sequenced clones
among Vb subfamilies as % of total (error bars indicate standard deviations). (B) T cells in Irga6 liver cored patches express TCR Vb8. Consecutive
cryo-sections of C57BL/6 adult mice liver were probed for Irga6 protein (1, green) and for TCR Vb8 protein (2, blue), respectively; frames show
enlarged images. Arrows indicate T cells expressing Vb8 TCR. Microscope magnification is 200x. (C) TCR Vb8 chains in liver cored patches have
variable junctional regions, shown in alignment of TCR Vb8.2 junctions from (A) above. Junction sequences for all Vb8 clones from liver cored
patches are given in Additional file 5: Table S3. (D) TCR Va14 dominates Va usage in Irga6 liver cored patches. TCR Va usage was assessed by
amplifying Va14, 2, 8 and 17 individually from cDNA of liver cored patches or lymph node with nested-RT PCR (see Methods section: upper
panel). GAPDH served as control. RT-PCR products of Va8 and Va14 were cloned and sequenced. One hundred per cent of Va8 PCR products
from LN T cell were Va8, whereas 100% of the Va8 products from liver CP were non-specific. For liver CP, 70 out of 72 clones from the Va14
PCR were Va14; two clones were Va11. For LN all 40 identified Va14 clones were Va11. The histograms (lower panel) show the corrected
distribution of Va8 and Va14/11 usage. (E) Alignment of representative TCR Va14/Ja18 junction regions found in liver cored patches. For full
junction information on all Va14 and Va11 clones see Additional file 5: Table S3.
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by RT-PCR a number of specific Va families from
lymph node cells and from mononuclear cell cores (Fig-
ure 3D). In lymph node T cells a weak signal for Va14
was seen, compared with strong signals for Va2 and
Va8. From the mononuclear core cells a strong signal
was seen for Va14, an unclear result for Va2 and a
weaker signal for Va8. However, the true excess of
Va14 in the core cells was striking since the weak signal
of Va14 from lymph nodes proved, on cloning and
sequencing, to be due, with a single exception, to the
amplification of Va11 which is closely related to Va14.
In contrast, all except one of the clones amplified for
Va14 from mononuclear cell cores of liver patches were
indeed Va14 (Figure 3D). Thus, the TCR V-gene usage
of the mononuclear cell cores was consistent with the
TCRs of iNKT cells. This was further confirmed by
showing that exclusively the canonical Ja18 was used
with no length variation (Figure 3E).
If the NKT function is dependent on a dedicated Vb8/
Va14 TCR and is responsible for the high expression
patches in liver and kidney, these should be reduced in
mice carrying deletions in the TCR Vb gene array that
include the Vb8 family of sequences [17,18]. We analysed
the numbers of liver core patches and kidney high
expression patches in inbred mouse strains of known
TCR Vb genotype, in each case comparing patch fre-
quencies with C57BL/6. Tissues from the A/J and
C57BRcdJ strains, with normal Vb8 gene representation,
were similar to C57BL/6 (Figure 4A). However, five
strains with Vb8 deletions (SWR/J, SJL/J, RIIIS/J, C57BR/
J and C57L/J) all showed reduction down to a more or
less complete loss of cored liver patches and kidney
patches. The residual kidney and cored liver patches in
these strains may, perhaps, be attributed to usage of Vb2
and Vb7, V-genes that also contribute to a minority of
iNKT receptors [19], although we did not find these sub-
groups in our analysis in C57BL/6 (Figure 3A). SWR
mice had an unexplained deficit of plain liver patches.
If the Irga6 high expression foci with mononuclear
cores associated with high IFN-g production were,
Figure 4 Irga6 focal expression is reduced in mouse strains with genetic defects affecting invariant natural killer T cells (iNKT)
differentiation. (A) Irga6 focal expression was assayed in organs from mouse strains carrying natural deletions in the T-cell receptor (TCR) Vb8
locus - namely, SWR/J, SJL/J, C57BR/J, C57L/J and RIIIS/J, A/J and C57BR/cdJ strains - that have an intact TCR Vb locus, were also tested.
Quantification of Irga6 expression foci was carried out as described (Figure 2A). Focus numbers from the test strains are presented as a
percentage of the numbers found in C57BL/6. (B and C) Irga6 focal expression was assayed for organs from mice deficient in CD1 d, Ja18, TAP1,
MHC II Ab or MAVs. Quantification for Irga6 focal expression was carried out and presented as described in Figure 2A. For raw data see
Additional file 1: Table S1.
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indeed, due to iNKT cells, they should also be absent
from mice deficient in the essential ligand-presenting
molecule CD1 d [20,21] and in mice deficient in iNKT
cells as a result of deletion of the diagnostic Ja18 T cell
receptor segment [22]. Both these predictions were ful-
filled, with a substantial loss of high Irga6 expression
patches from the kidney and cored patches from the
liver in both mutants (Figure 4B). The patches of high
Irga6 expression in the liver without mononuclear cores
were not affected in either case. In order to find out
whether CD4+ or CD8+ T cells play any additional role
in the induction of high Irga6 expression patches,
organs from mice lacking MHC Abb (CD4+ T cell defi-
cient [23]) and TAP1 (CD8+ T cell deficient [24]) were
also examined. Patches of high Irga6 expression were
normal in liver and kidney from both strains. Thus,
iNKT cells alone appear to be responsible for the high
Irga6 expression foci.
We present direct evidence for the constitutive activa-
tion of mouse iNKT cells in two organs, the liver and
the kidneys, generating small foci of high IFN-g expres-
sion detected by the local high expression of an IFN-g-
inducible cytoplasmic protein, Irga6. In a previous study,
we surveyed the pattern of constitutive Irga6 expression
in a number of other organs and high expression foci
were not seen [4]. The liver and kidneys thus appear to
be special in this respect. Our results suggest a local
activation event that triggers production of type II inter-
feron by iNKT cells. The mouse liver sinusoids are
known to contain a major population of NKT cells and
NKT cells have been reported in the kidney, probably
corresponding to the T cells identified in the tubulo-
interstitial spaces [25]. Dendritic cells (DC) and hepatic
stellate cells (Ito cells) [26] can both present exogenous
a-GalCer via CD1 d to iNKT cells. Stellate cells of
the liver sinusoids have also been shown to be IL-15-
dependent activators of iNKT cells to proliferation in
the absence of exogenous antigen [26]. An apparently
similar cell type is also found in the tubular cortex of
the kidney essentially co-localizing with dendritic cells
[5,27]. Both DC and stellate cells are strong candidates
for the activating cell implied by our experiments, but
this does not, by itself, account for the focal triggering
event. Our experiments with germ-free and TLR-
deficient mice make bacterial products acting on DC
TLRs [28,29] an unlikely cause. More plausible would,
perhaps, be a locally reactivating endogenous retrovirus
triggering DC or stellate cells and, thereby, iNKT cells
locally. Arguing against a primary viral stimulus, we
could show no deficit in liver cored high expression
patches or kidney patches in organs from mice deficient
in MAVS/CARDIF [30], the common activation pathway
of the cytosolic RIG helicases that act as viral sensors
(Figure 4C).
It will be interesting to know how the spontaneous
activation of iNKT cells and consequent constitutive
IFN-g production in liver and kidney of major inbred
strains of mouse affects immunological function in these
organs. NKT cells have been identified very recently as
a minority population among normal resident lympho-
cytes in mouse kidney and both an excitatory role in
ischaemia-reperfusion injury [31] and an inhibitory role
in experimental glomerular nephritis induction by anti
glomerular basement membrane antibody [32,33] have
been described. Likewise, the large population of NKT
cells that patrol the liver sinusoids [34] have been impli-
cated in various liver disorders [35], but their sponta-
neous, focal activation has not been reported.
Spontaneous focal activation of NKT cells in the liver
and kidney with high local levels of IFN-g will have to
be considered in future studies of immune function in
these organs.
Conclusions
Invariant natural killer T (iNKT) cells are activated
spontaneously in mouse liver and kidney. These activa-
tion events are local, probably extravascular, and result
in the local secretion of IFN-g. This in turn results in
the local induction of IFN-g-responsive genes in non-
immune tissue cells, namely hepatic parenchymal cells
and renal tubular epithelial cells. These activation events
are spontaneous in the sense that they appear to be
independent of exogenous pathogenic material of bac-
terial or viral origin. The cause of individual activation
events is still unclear. In general, however, the results
are consistent with a widely held view that iNKT cells
are rendered spontaneously active by interaction with an
endogenous ligand. In this study we demonstrate these
activation events histologically. Further investigations
may reveal the nature of the stimulatory event that lies
at the heart of each activating focus. It will be important
to generalise these findings to the human case, and to
assess the implications of these findings for liver and
kidney immunopathology.
Methods
Mice and organ preparation
C57BL/6J mice were obtained from the specific patho-
gen-free mouse facility in the Institute for Genetics Uni.
Köln. We are enormously indebted to the many collea-
gues and institutions that provided mice or organs for
this study. TLR2-/- [36], TLR4-/- [37], TLR9-/- [38],
TLR2/4-/-[39] and MyD88-/- [40] mice were provided by
Professor Dr Marina Freudenberg (Max Planck Institute
for Immunobiology, Freiburg). IFN-g-/- mice [8], IFN-
receptor deficient mice (IFNAR, [10]), (IFNGR, [9]) and
STAT-1-/- mice [41] were provided by Dr Thomas
Kolbe (University of Veterinary Medicine, Vienna).
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RAG-1-/- mice [13] were provided by Dr Heike Weigh-
ardt (Technische Universitaet Muenchen, Munich). JHT
mice [14] were provided by Dr Ari Waisman (Johannes
Gutenberg-Universität Mainz, Mainz, Germany). Germ-
free C57BL/6 mice were provided from three indepen-
dent facilities, namely, University of Zürich, Zürich,
Switzerland (Mr Rudolf Jörg), the Gulbenkian Institute
of Science, Oeiras, Portugal (Dr Jocelyne Demengeot)
and the Karolinska Institute, Stockholm. CD1d-/- mice
[21] were provided by Professor Luc van Kaer (Vander-
bilt University Medical Center, TN, USA). Ja18-/- mice
[22] were provided by Dr Maria C. Leite-de-Moraes,
Hôpital Necker, Paris, France. MAVS/CARDIF-deficient
mice [30] were provided by Dr Jürg Tschopp (Lausanne,
Switzerland). MHC Ab-/- mice [23] were provided by Dr
Jocelyne Demongeot (Gulbenkian Institute of Sciences,
Oeiras, Portugal). TAP1-/- mice [24] were purchased
from the Jackson Laboratory (Maine, US). For all assays,
wild-type C57BL/6 mice from the same donor facility
were used as controls. To control germ-free C57BL/6
mice, C57BL/6 mice from colonies maintained at SPF
level from the same suppliers were used. All the above
mice were on the C57BL/6J background. SWR/J, SJL,
C57BR/J, C57L/J, RIIIS/J, A/J and C57BR/cdJ strains
were purchased from The Jackson Laboratory (Maine,
USA). In most cases, liver and kidneys were removed at
the donor animal facility, immediately fixed in cold
TBS/4% paraformaldehyde and shipped at 4°C by the
quickest route to the Institute for Genetics in Cologne,
Germany.
Tissue preparation
For paraffin sections, mouse tissues were fixed in TBS/
4% paraformaldehyde at 4°C and dehydrated through an
ethanol series at 4°C (50%, 70%, 90% and 96%). Tissues
were then transferred into isopropanol and finally into a
paraffin:isopropanol (1:1) solution at 60°C. The isopro-
panol was evaporated and fresh paraffin was then
replenished several times at 60°C before the tissues
(in paraffin) were moved to room temperature. The
embedded tissues were cut with a microtome RM 2065
(Leica Microsystems, Wetzlar, Germany) into 6 μm
thick serial sections. For cryosections, mouse liver was
snap-frozen in liquid nitrogen and cut into consecutive
serial sections (6 μm) using a cryotome CM 3050 S
(Leica Microsystems).
Immunohistochemistry
Paraffin sections were de-waxed in xylene and post-fixed
in 4% paraformaldehyde (1 h, RT). For Irga6 or Irgm3
staining, protein epitopes were demasked (10 min, boil-
ing) in 10 mM citrate buffer (pH 6.0). For F4/80 or CD3
staining, protein epitopes were demasked by 0.1% Tryp-
sin (SIGMA Type II) solution (0.1% CaCl2, pH7.8) for
30mins at 37°C or in 1 mM EDTA (pH8.0) for 10 min
at 100°C, respectively. Sections were then saturated with
quenching buffer (0.3% H2O2, 20 min). After phosphate
buffered saline (PBS) washing, the sections were probed
either with rabbit anti-Irga6 antiserum 165/3 [42] or
mouse anti-Irgm3 mAb (BD Transduction Laboratory)
in DAKO diluent. HRP-staining was carried out with
the horseradish peroxidase (HRP)-substrate kit Histo-
Green (Linaris, Wetzlar, Germany). Nuclei were coun-
terstained with Nuclear Fast Red. For Irga6 and F4/80
or CD3 double staining, Irga6 was first probed with
165/3 and stained with HRP-substrate AEC (Sigma,
MO, USA). The sections were then washed with PBS
(1 h) and subsequently probed with anti-F4/80 mAb
(Serotec, NC, USA) or anti-CD3 mAb (Vector Labora-
tories, Linaris). The AP-staining was then carried out
with AP-substrate kit III (Vector laboratory, Linaris).
For staining of cryo-sections, sections were fixed first
with cold acetone (10 min), before probing with anti-
Irga6 antiserum 165/3 or anti-TCR Vb8.1/8.2 mAb (BD
Pharmingen, CA, USA). The sections were then stained
with the HRP-substrate kit HistoGreen for Irga6 or with
AP-substrate kit III for TCR Vb 8. Samples were ana-
lysed using Zeiss Axioplan II microscope (Zeiss, Jena,
Germany) equipped with SPOT RT slider digital camera
(Diagnostic Instruments, MI, USA).
Quantitation of Irga6 expression foci in histological
sections
Irga6 high expression foci were counted on stained
6 μm histological sections using 100× total magnifica-
tion. Sections 300 μm apart were examined in order to
avoid repeated counts of the same high expression
patch. A total of 30 fields were counted from each
organ, from which the mean number of high expression
patches per field was estimated. The raw data from all
such determinations are presented in Additional file 1:
Table S1.
Laser microdissection
Consecutive serial cryosections (6 μm) for liver were
prepared using a cryotome CM 3050 S (Leica Microsys-
tems) and sections were carried on PALM Membrane-
Slides (P.A.L.M. Microlaser Technologies, Bernried,
Germany), which was covered with a polyethylene
naphthalate membrane. In order to avoid the RNA
degradation caused by the staining of sections with anti-
body, the following procedure was followed. Consecutive
sections were numbered (1, 2, 3, 4...). All sections with
odd-numbers (1, 3...) were on one slide (named ‘A’) and
the sections with even numbers (2, 4...) on another slide
(named ‘B’). Both slides were then fixed in 70% ethanol
(-20°C). The B slide was stored at -80°C and the A slide
was stained for Irga6 with 165/3 using histogreen
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substrate. Geographical locations of Irga6 focal expres-
sion on the A slide were recorded photographically. The
B slide was then stained only with Nuclear Fast Red,
dehydrated in an ethanol series (70%, 96%, 100% 2 min
each) and dried at 50°C. Irga6 focal expression was
located on the B slide by referring to the photos of adja-
cent sections on the A slide. The Irga6 expression foci
and non-focus region on the B slides were then col-
lected by laser microdissection (LMD) equipment gener-
ously made available by Dr Margarete Odenthal
(Institute for Pathology, University of Cologne, Cologne,
Germany) consisting of an Interface Microbeam Mini
laser (P.A.L.M Microlaser Technologies) and an Axio-
vert 135 microscope (Zeiss). Total RNA from the dis-
sected samples (50-100 foci) was extracted with the
RNeasy Micro kit (QIAGEN, Hilden, Germany) and
cDNA was synthesized with half of the total RNA with
the Superscript First-Strand Synthesis System for RT-
PCR kit (Invitrogen, CA, USA).
Real-time PCR
PCR was carried out in a Light Cycler I System (Roche,
Berlin, Germany) using a LightCycler SYBR Green I PCR
kit (Roche). The 5’ primers specific for Irga6 1A and 1B
together with the common 3’ primer on the coding exon
were used to detect expression level of Irga6-1A and
Irga6-1B transcript forms as target genes [4]. Mouse
GAPDH gene was used as a reference gene and input
control (for primers see Additional file 4: Table S2). 2-4
μL of cDNA from materials collected by LMD was used
as templates. Primer efficiency for Irga6-1A, -1B or
mGAPDH was determined using liver cDNA dilution
series (1, 1/10, 1/100...) as templates as described pre-
viously [43]. The proportional increase in Irga6-1A or
-1B expression for ‘foci’ to ‘non-foci’ was then deter-
mined according to [43]. Melting curve analyses were
performed in order to verify the amplification specificity.
Each sample was tested in duplicate or triplicate. In order
to determine whether the final PCR products amplified
for Irga6-1A were -1A specific, 1A PCR products were
cloned in to pGEM-T-easy (Promega, CA, USA) vector
and sequenced. The percentage of -1A specific clones
was then calculated. For Irga6 high expression foci, all
clones amplified for Irga6-1A were -1A, while for the
non-focal material, only 5.9% of clones amplified for
Irga6-1A were -1A. The directly determined enrichment
factor of 27.9 for Irga6-1A in Irga6 high expression foci
(Figure 2C) can, therefore, be multiplied a factor of 16.9
(100/5.9) in order to give a relative enrichment of over
470 in Irga6-1A compared with non-focal tissue.
Nested-RT-PCR
Total RNA from mouse liver or lymph nodes was
extracted using the RNeasy Mini kit (QIAGEN) and
cDNA was synthesized using the Superscript First-
Strand Synthesis System for RT-PCR kit (Invitrogen).
One mcrolitre cDNA from the liver and T cells or 2-4
μL of cDNA from laser dissected materials were used in
each of the following RT-PCR reactions as templates.
Primers located in different exons were used to generate
specific products only from cDNA but not from geno-
mic DNA (Additional file 4: Table S2). For nested-PCR,
1 μL PCR product of the first round of PCR was used as
template for the second PCR, making use of a nested
primer and the common 3’ or 5’ primer. The cycle num-
ber was always 45 for each round of PCR. All final PCR-
products were verified by sequencing.
TCR repertoire screening
In order to determine the TCR Vb usage and Va14
junctional diversity, nested-RT-PCR was performed.
cDNA from more than 50 Irga6 cored patches collected
by LMD or cDNA of 1000 lymphocytes from mesenteric
and cervical lymph nodes were synthesized and nested-
RT-PCR was performed as described in [4] The Vb8
and Cb primers [44] Va14 and Ca primers [16], Va2,
Va8, Va17 primers [45] were described before (Addi-
tional file 4: Table S2). The final products of nested-
PCR were cloned into pGEM-T-easy (Promega) and
sequenced. The sequences were compared to classical
TCR V sequences in the database online using IMGT/
V-QUEST http://imgt.cines.fr/. Clones with a sequence
identity of more than 95% to known TCR V sequences
were identified as correct TCR V clones. Clones were
classified into groups with same junctions. Representa-
tives from each group were selected aligned and ana-
lysed with free software GeneDoc (Version 2.6.002;
http://www.nrbsc.org) and Vector NTI (Version 9, Invi-
trogen). See Additional file 5: Table S3 for complete
junction sequence data.
Additional material
Additional file 1: Table S1 - Quantification of Irga6 focal expression
patches in liver and kidneys of various mouse strains. Focal Irga6
expression was quantified on stained histological sections of liver and
kidney from strains of mice listed, as described in Materials and Methods.
Each value in the table is the mean number of expression foci per
microscope field averaged over 30 fields. WT = wild type; KO = knock-
out, IFN R are mice lacking IFN-type I (IFNAR) and type II (IFNGR)
receptors respectively; SPF = specific pathogen free; GF = germ-free;
Portugal, Sweden and Switzerland refer to the national origins of three
independent germ-free C57BL/6 strains.
Additional file 2: Figure S1 - Irga6 is over-expressed in the kidney
of RAG and JHT mice. Paraffin sections from kidneys of RAG or JHT
mice were probed for Irga6 protein (Green). Nuclei were counterstained
in red. Kidneys from WT control mice were also included.
Additional file 3: Figure S2 - Irgm3 is co-expressed at Irga6
expression foci in liver and kidney. Serial paraffin sections (6 μm) of
organs from C57BL/6 adult mice were prepared. In each case, two
adjacent serial sections were probed for Irga6 (1, green) and Irgm3
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protein (2, green) respectively. Frames show enlarged images. Nuclei
were counter-stained in red.
Additional file 4: Table S2 - List of primers used in RT-PCR and Real
time PCR.
Additional file 5: Table S3 - Sequence comparison of identified TCR
clones. Sequences of identified TCR Vb8 (A) and Va14/11 (B) clones from
Irga6 liver cored patches, and sequences of identified TCR Va11 (C)
clones from lymph nodes were compared and classified into different
junction types. The number of clones belonging to each junction type
was listed. Vb, Db, Jb, Va and Ja subfamily names were labeled (’ - ‘
means not identifiable). TCR Vb-N(D)N-Jb or TCR Va-N-J junctional
sequences were displayed. ‘Short’ indicates that the length of the
sequence was too short to identify the entire junctional region.
Abbreviations
a-GalCer: alpha-galactosyl ceramide; F: foci; NF: non-focus region; iNKT:
invariant natural killer-like T cell; FN: interferon; IFNAR: IFN type I receptor;
IFNGR: IFN type II receptor; IL: interleukin; HRP: horseradish peroxidase; IRG:
immunity-related GTPases; MHC: major histocompatibility; MMTV: mouse
mammary tumour virus; PBS: phosphate buffered saline; PCR: polymerase
chain reaction; qRT-PCR: quantitative reverse transcription PCR; TCR: T-cell
receptor; TLR: Toll-like receptor.
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